Hans Peter Hasler's most recent trade in Gain Therapeutics Inc was a trade of 15,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gain Therapeutics Inc | Hans Peter Hasler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Minerva Neurosciences Inc | Hans Hasler Peter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Gain Therapeutics Inc | Hans Peter Hasler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Gain Therapeutics Inc | Hans Peter Hasler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Gain Therapeutics Inc | Hans Peter Hasler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2022 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Minerva Neurosciences Inc | Hans Peter Hasler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 2,500 | 2,500 | - | - | Stock Option (right to buy) |